Burcon Sets Third Fiscal Quarter 2014 Conference Call for Thursday, February
13, 2014 at 5:00 p.m. ET
VANCOUVER, British Columbia, Jan. 27, 2014 (GLOBE NEWSWIRE) -- Burcon
NutraScience Corporation (TSX:BU) (Nasdaq:BUR), a leader in developing
functionally superior plant-based proteins, will hold a conference call on
Thursday, February 13, 2014 at 5:00 p.m. Eastern time to discuss its results
for the fiscal third quarter ended December 31, 2013. Financial results will
be announced in a news release prior to the call.
Burcon's president and COO, Johann F. Tergesen, will host the presentation,
followed by a question and answer period.
Date: Thursday, February 13, 2014
Time: 5:00 p.m. Eastern time (2:00 p.m. Pacific time)
Dial-in (toll/international): 1-480-629-9712
Toll-free dial-in (North America): 1-877-941-1431
Conference ID: 4663446
A telephone replay of the call will be available after 8:00 p.m. Eastern time
on the same day through March 13, 2014.
Replay dial-in (toll/international): 1-858-384-5517
Toll-free dial-in (North America): 1-877-870-5176
Replay conference ID: 4663446
About Burcon NutraScience Corporation
Burcon NutraScience is a leader developing functionally superior plant-based
proteins. The company has developed a portfolio of composition, application,
and process patents originating from a core protein extraction and
purification technology. Burcon's CLARISOY™ soy protein offers clarity and
high-quality protein nutrition for low pH beverage systems; Peazazz® is a
uniquely soluble and clean-tasting pea protein; and Puratein®, Supertein™ and
Nutratein® are canola protein isolates with unique functional and nutritional
attributes. For more information about the company, visit www.burcon.ca.
ON BEHALF OF THE BOARD OF DIRECTORS
"Johann F. Tergesen"
Johann F. Tergesen
President and Chief Operating Officer
The TSX has not reviewed and does not accept responsibility for the adequacy
of the content of the information contained herein. This press release
contains forward-looking statements or forward-looking information.
Forward-looking statements or forward-looking information involve risks,
uncertainties and other factors that could cause actual results, performances,
prospects and opportunities to differ materially from those expressed or
implied by such forward-looking statements. All statements other than
statements of historical fact included in this release are forward-looking
statements, including, without limitation, statements regarding plans and
timing for the introduction or enhancement of our products, statements about
future market conditions, supply and demand conditions, and other
expectations, intentions and plans contained in this press release. There can
be no assurance that such statements will prove to be accurate and actual
results and future events could differ materially from those anticipated in
such statements or information. Important factors that could cause actual
results to differ materially from Burcon's plans and expectations include the
actual results of marketing activities, adverse general economic, market or
business conditions, regulatory changes and other risks and factors detailed
herein and from time to time in the filings made by Burcon with securities
regulators and stock exchanges, including in the section entitled "Risk
Factors" in Burcon's annual information form dated June 25, 2013. Any
forward-looking statement or information only speaks as of the date on which
it was made and, except as may be required by applicable securities laws,
Burcon disclaims any intent or obligation to update any forward-looking
statement, whether as a result of new information, future events or otherwise.
Although Burcon believes that the assumptions inherent in the forward-looking
statements are reasonable, forward-looking statements are not guarantees of
future performance and accordingly undue reliance should not be put on such.
CLARISOY is a trademark of Archer Daniels Midland Company.
CONTACT: Media & Industry Contact:
Director, Corporate Development
Burcon NutraScience Corporation
Tel 604-733-0896, Toll-free 888-408-7960
Investor Relations Contact:
Michael Koehler or Matt Glover
Liolios Group Inc.
Press spacebar to pause and continue. Press esc to stop.